Menopause-related side effects in HR+ early breast cancer: insights from clinical practice.

Ther Adv Med Oncol · 2025 · PMC12317255 · PMID 40755832

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

All four analyzed symptoms showed a trend of declining by the end of therapy (36 months), but the percentage of patients reporting side effects remained higher compared to baseline values.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.